BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 24836184)

  • 21. A novel index for staging hepatitis B related liver cirrhosis in patients with hepatocellular carcinoma.
    Wu J; Chen Y; Zuo C; Kuang N; Li R; Li Q; Ruan J; Cui E; Xu R; Yu J
    Sci Prog; 2021; 104(2):368504211018052. PubMed ID: 34003700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sparse logistic regression revealed the associations between HBV PreS quasispecies and hepatocellular carcinoma.
    Jia JA; Zhang S; Bai X; Fang M; Chen S; Liang X; Zhu S; Wong DK; Zhang A; Feng J; Sun F; Gao C
    Virol J; 2022 Jun; 19(1):114. PubMed ID: 35765099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional genetic variants of the disulfidptosis-related INF2 gene predict survival of hepatitis B virus-related hepatocellular carcinoma.
    Wei J; Wen Q; Zhan S; Cao J; Jiang Y; Lian J; Mai Y; Qiu M; Liu Y; Chen P; Lin Q; Wei X; Wei Y; Huang Q; Zhang R; He S; Yuan G; Wei Q; Zhou Z; Yu H
    Carcinogenesis; 2024 Apr; 45(4):199-209. PubMed ID: 38270181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating hypoxia marker carbonic anhydrase IX (CA9) in patients with hepatocellular carcinoma and patients with cirrhosis.
    Finkelmeier F; Canli Ö; Peiffer KH; Walter D; Tal A; Koch C; Pession U; Vermehren J; Trojan J; Zeuzem S; Piiper A; Greten FR; Grammatikos G; Waidmann O
    PLoS One; 2018; 13(7):e0200855. PubMed ID: 30011326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Machine learning algorithms outperform conventional regression models in predicting development of hepatocellular carcinoma.
    Singal AG; Mukherjee A; Elmunzer BJ; Higgins PD; Lok AS; Zhu J; Marrero JA; Waljee AK
    Am J Gastroenterol; 2013 Nov; 108(11):1723-30. PubMed ID: 24169273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic role of computed tomography analysis using deep learning algorithm in patients with chronic hepatitis B viral infection.
    Yoo J; Cho H; Lee DH; Cho EJ; Joo I; Jeon SK
    Clin Mol Hepatol; 2023 Oct; 29(4):1029-1042. PubMed ID: 37822214
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Prospective Cohort Study of Inter-Alpha-Trypsin Inhibitor Heavy Chain 4 as a Serologic Marker in Relation to Severity and Functional Outcome of Acute Intracerebral Hemorrhage.
    Shentu HS; Chen YH; Cheng ZY; Fu B; Fu YH; Zheng SF; Li C
    Neuropsychiatr Dis Treat; 2023; 19():2363-2379. PubMed ID: 37954033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The interplay between chronic hepatitis B and diabetes mellitus: A narrative and concise review.
    Huang SC; Kao JH
    Kaohsiung J Med Sci; 2024 Jan; 40(1):6-10. PubMed ID: 37732697
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Profile and clinical significance of interferon gamma-inducible protein-10 (IP-10) and its receptor in patients with hepatocellular carcinoma.
    Li Y; Wang C; Yin X; Jiang L; Li X; Yang J
    J Cancer Res Clin Oncol; 2023 Nov; 149(16):14879-14888. PubMed ID: 37599316
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive three-biomarker panel in peripheral blood mononuclear cells for detecting hepatocellular carcinoma.
    Fayazzadeh S; Ghorbaninejad M; Rabbani A; Zahiri J; Meyfour A
    Sci Rep; 2024 Mar; 14(1):7527. PubMed ID: 38553531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum Expression Level of MicroRNA-122 and its Significance in different Stages of Hepatitis B Virus Infection.
    Singh SP; Maurya V; Kumar K; Singh D; Verma P; Samanta D; Verma MK
    Cell Mol Biol (Noisy-le-grand); 2023 Jun; 69(6):36-40. PubMed ID: 37605594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of a Nomogram Using the Inflammatory Risk Score for Prognostication in Moderate and Advanced Hepatocellular Carcinoma Associated with Hepatitis B Virus.
    Chen H; Yang R; Yu X; Li K; Xue P; Peng W; Zeng P
    Balkan Med J; 2024 Mar; 41(2):130-138. PubMed ID: 38425017
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum ITIH5 as a novel diagnostic biomarker in cholangiocarcinoma.
    Chen M; Ma J; Xie X; Su M; Zhao D
    Cancer Sci; 2024 May; 115(5):1665-1679. PubMed ID: 38475675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alteration of serum bile acid profiles of HBV-related hepatocellular carcinoma identified by LC-MS/MS.
    Dai S; Zhu J; Chen X; Zheng L; Li X; Liu L
    J Cancer Res Clin Oncol; 2024 Mar; 150(3):157. PubMed ID: 38528272
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating CTLA-4 levels and CTLA4 polymorphisms associate with disease condition and progression and hepatocellular carcinoma patients' survival in chronic hepatitis B virus infection.
    Wang L; Li N; Fan X; Wang X; Zhang X; Zhang K; Han Q; Lv Y; Liu Z
    Int Immunopharmacol; 2020 Mar; 82():106377. PubMed ID: 32163858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analytical and Clinical Evaluation of a Chemiluminescent Immunoassay to Detect Serum Chitinase-3-like Protein 1 in HBV-Related Liver Diseases.
    Liao Y; Peng S; Huang L; Li Z; Hu J; Xu R; Tang W; Zhuang J
    Int J Anal Chem; 2024; 2024():6688819. PubMed ID: 38304922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Construction of a diagnostic model for hepatitis B-related hepatocellular carcinoma using machine learning and artificial neural networks and revealing the correlation by immunoassay.
    Zhang S; Jiang C; Jiang L; Chen H; Huang J; Gao X; Xia Z; Tran LJ; Zhang J; Chi H; Yang G; Tian G
    Tumour Virus Res; 2023 Dec; 16():200271. PubMed ID: 37774952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The expression of DAMP proteins HSP70 and cancer-testis antigen SPAG9 in peripheral blood of patients with HCC and lung cancer.
    Ren B; Luo S; Xu F; Zou G; Xu G; He J; Huang Y; Zhu H; Li Y
    Cell Stress Chaperones; 2017 Mar; 22(2):237-244. PubMed ID: 28028759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integrating transcriptomics, glycomics and glycoproteomics to characterize hepatitis B virus-associated hepatocellular carcinoma.
    Li Z; Zhang N; Dong Z; Wang X; Zhou J; Gao J; Yang Y; Li J; Guan F; Zhou Y; Tan Z
    Cell Commun Signal; 2024 Apr; 22(1):200. PubMed ID: 38561745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression level of glutamine synthetase is increased in hepatocellular carcinoma and liver tissue with cirrhosis and chronic hepatitis B.
    Long J; Wang H; Lang Z; Wang T; Long M; Wang B
    Hepatol Int; 2011 Jun; 5(2):698-706. PubMed ID: 21484108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.